Table 2 Laboratory characteristics of the participants in the CPH CKD Cohort undergoing MDCT

No. of participants (n, %)

580

47 (8.1)

91 (15.7)

298 (51.4)

114 (19.7)

30 (5.2)

–

Creatinine clearance (mL/min)

67 (45–100)

126 (105–147)

118 (96–130)

68 (52–83)

36 (29–46)

22 (18–26)

< 0.001

Urine albumin/creatinine ratio (10⁻³)

105 (19–670)

48 (12–223)

54 (9–543)

73 (13–421)

212 (35–874)

1050 (326–2141)

< 0.001

24-h urine protein (g/d)

0.3 (0.1–1.1)

0.2 (0.1–0.7)

0.2 (0.1–1.0)

0.2 (0.1–0.9)

0.4 (0.2–1.4)

1.8 (0.6–3.5)

< 0.001

P-HDL-C (mmol/l)

1.5 (0.0)

1.7 (0.1)

1.7 (0.1)

1.5 (0.0)

1.4 (0.1)

1.2 (0.1)

< 0.001

P-LDL-C (mmol/l)

3.1 (0.0)

3.2 (0.1)

3.4 (0.1)

3.0 (0.1)

2.9 (0.1)

2.8 (0.2)

0.004

P-triglycerides (mmol/l)

1.5 (1.0–2.2)

1.0 (0.8–2.0)

1.2 (0.9–2.0)

1.6 (1.1–2.2)

1.6 (1.2–2.2)

1.8 (1.4–2.6)

0.008

P-glucose (mmol/l)

5.7 (5.1–6.4)

5.4 (4.8–6.0)

5.5 (5.0–6.0)

5.7 (5.2–6.8)

5.8 (5.2–6.7)

5.8 (5.3–6.9)

< 0.001

P-Ca2+ (mmol/l)

1.22 (0.00)

1.23 (0.01)

1.23 (0.00)

1.22 (0.00)

1.20 (0.01)

1.18 (0.01)

< 0.001

P-phosphate (mmol/l)

1.08 (0.01)

0.98 (0.03)

0.98 (0.02)

1.02 (0.01)

1.20 (0.02)

1.55 (0.05)

< 0.001

P-Mg (mmol/l)

0.84 (0.00)

0.78 (0.01)

0.8 (0.01)

0.83 (0.01)

0.87 (0.01)

0.91 (0.03)

< 0.001

P-PTH (pmol/l)

7.2 (4.7–11.5)

4.4 (3.5–5.4)

4.8 (4.0–6.4)

7.2 (5.1–10.0)

12.7 (8.3–18.9)

25.0 (14.3–30.7)

< 0.001